Amygdala Neurons Reduced in Adulthood With Autism

Share this content:
Amygdala Neurons Reduced in Adulthood With Autism
Amygdala Neurons Reduced in Adulthood With Autism

TUESDAY, March 27, 2018 (HealthDay News) -- In neurotypical development, there is an increase in the number of mature neurons in the basal and accessory basal nuclei, whereas an initial excess of amygdala neurons is seen during childhood in autism spectrum disorder (ASD), followed by a reduction in adulthood, according to a study published online March 20 in the Proceedings of the National Academy of Sciences.

Thomas A. Avino, Ph.D., from the University of California, Davis, in Sacramento, and colleagues reported the results of a stereological analysis of the number of neurons in amygdala nuclei of 52 human brains aged 2 to 48 years. Twenty-four brains were neurotypical, and 28 were ASD.

The researchers found that the number of mature neurons in the basal and accessory basal nuclei increased from childhood to adulthood in neurotypical development, which coincided with a decrease of immature neurons within the paralaminar nucleus. In contrast, there was initial excess of amygdala neurons during childhood in individuals with ASD; across nuclei there was a reduction in neurons in adulthood.

"We propose that there is a long-term contribution of mature neurons from the paralaminar nucleus to other nuclei of the neurotypical human amygdala and that this growth trajectory may be altered in ASD, potentially underlying the volumetric changes detected in ASD and other neurodevelopmental or neuropsychiatric disorders," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »